KLRS
Kalaris Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.91
−4.50%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.52
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 11, 2026
- EPS actual
- -$0.48
- EPS estimate
- -$0.49
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 4
- EPS misses (12Q)
- 2
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +10.6%
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 11, 2026 | -$0.49 | -$0.48 | Beat 3.03% | — |
| May 12, 2026 | -$0.52 | -$0.46 | Beat 11.54% | — |
| Mar 17, 2026 | -$0.59 | -$0.44 | Beat 24.91% | — |
| Nov 12, 2025 | -$0.66 | -$0.64 | Beat 3.03% | — |
| Aug 13, 2025 | -$0.51 | -$0.61 | Miss -19.61% | — |
| May 14, 2025 | -$0.78 | -$2.52 | Miss -223.08% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026